Tiny study looks at hepatitis c Virus's hidden protein partners
NCT ID NCT02795403
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study aims to identify human proteins that stick to hepatitis C virus particles in patient blood samples. By understanding which proteins the virus uses to survive and spread, researchers hope to find new targets for future treatments. Ten adults with chronic hepatitis C each provided two large blood samples for analysis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could reveal new targets for future hepatitis C treatments.
- What could go wrong
- This is a very small, early-stage study (10 participants) focused on basic biology, not a treatment trial. Findings may not lead to any new therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS C are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service d'Hépato-Gastroentérologie Lyon Croix-Rousse Hospices Civils de Lyon
Lyon, 69004, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A Finger-Prick could change the fight against hepatitis c
- A simple finger prick could transform hepatitis c care
- Can coaching clinics curb HIV? a new strategy puts it to the test
- Can hepatitis c be cured in just 4 weeks? a new trial puts it to the test
- Can a simple roadside test catch liver disease before it turns deadly?
- Pharmacy-Based hepatitis c testing could cure more people on opioid therapy